TY - JOUR
T1 - Erythropoietic agents, iron and hemoglobina?? What happens beyond the trial setting: Observational data from the ANZDATA Registry
AU - McDonald, Stephen P
AU - Marshall, Mark R
AU - Kerr, Peter
AU - Russ, Graeme R
PY - 2003
Y1 - 2003
N2 - Background: The issues surroundinga nemiamanagement in patients receivingd ialysis therapy are complex
and widely debated. Although numerous trials have been published, clinical practice patterns may
differ, particularly in the presence of uncertainty about the optimal management of anemia in this setting.
Methods: We examined data from the Australia and New Zealand Dialysis and Transplant Registry
(ANZDATA) regarding use of erythropoietic agents (EA), hemoglobin, and ferritin concentrations and
transferrin saturation in 8476 prevalent dialysis patients in Australia and New Zealand duringth e
6months precedingMa rch 31, 2001. From this cross-sectional survey, we examined the distribution
of reported hemoglobin concentration, transferrin saturation, and ferritin concentration. Among hemodialysis
patients, other predictors of hemoglobin examined included urea reduction ratio (URR), age,
sex, and the presence of comorbidities.
AB - Background: The issues surroundinga nemiamanagement in patients receivingd ialysis therapy are complex
and widely debated. Although numerous trials have been published, clinical practice patterns may
differ, particularly in the presence of uncertainty about the optimal management of anemia in this setting.
Methods: We examined data from the Australia and New Zealand Dialysis and Transplant Registry
(ANZDATA) regarding use of erythropoietic agents (EA), hemoglobin, and ferritin concentrations and
transferrin saturation in 8476 prevalent dialysis patients in Australia and New Zealand duringth e
6months precedingMa rch 31, 2001. From this cross-sectional survey, we examined the distribution
of reported hemoglobin concentration, transferrin saturation, and ferritin concentration. Among hemodialysis
patients, other predictors of hemoglobin examined included urea reduction ratio (URR), age,
sex, and the presence of comorbidities.
UR - http://www3.interscience.wiley.com.ezproxy.lib.monash.edu.au/cgi-bin/fulltext/118815399/PDFSTART
U2 - 10.1111/j.1492-7535.2004.01103.x
DO - 10.1111/j.1492-7535.2004.01103.x
M3 - Article
SN - 1492-7535
VL - 8
SP - 257
EP - 264
JO - Hemodialysis International
JF - Hemodialysis International
IS - 3
ER -